Interest Paid, Excluding Capitalized Interest, Operating Activities in USD of NovoCure Ltd from 2016 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
NovoCure Ltd quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2016 to Q3 2025.
- NovoCure Ltd Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Sep 2025 was $2,843,000, a 4.08% decline year-over-year.
- NovoCure Ltd Interest Paid, Excluding Capitalized Interest, Operating Activities for the twelve months ending 30 Sep 2025 was $10,942,000, a 122% increase year-over-year.
- NovoCure Ltd annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $7,714,000, a 128467% increase from 2023.
- NovoCure Ltd annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $6,000, a 85.4% decline from 2022.
- NovoCure Ltd annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $41,000, a 59.4% decline from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Trailing 12 Months (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)